Importer of Controlled Substances Registration: Fisher Clinical Services, Inc., 29338 [2015-12328]
Download as PDF
<![CDATA[
29338
Federal Register / Vol. 80, No. 98 / Thursday, May 21, 2015 / Notices
Controlled substance
Schedule
Opium, raw (9600) .......................
Poppy Straw Concentrate (9670)
Tapentadol (9780) ........................
II
II
II
The company plans to import raw
Opium (9600) and Poppy Straw
concentrate (9670) to bulk manufacture
other controlled substances for
distribution to its customers. The
company plans to import an
intermediate form of tapentadol (9780)
to bulk manufacture tapentadol (9780)
for distribution to its customers. The
company plans to import Phenylacetone
(8501) in bulk for the manufacture of a
controlled substance.
Dated: May 15, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015–12323 Filed 5–20–15; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
[Docket No. DEA–392]
Phenylacetone (8501) ..................
Coca Leaves (9040) .....................
Opium, raw (9600) .......................
Poppy Straw Concentrate (9670)
Schedule
II
II
II
II
The company plans to import the
listed controlled substances for the
manufacture of controlled substances in
bulk for distribution to its customers.
In reference to Phenylacetone (8501),
the company plans to import the
controlled substance for the bulk
manufacture of amphetamine products
for sale to its customers.
[FR Doc. 2015–12325 Filed 5–20–15; 8:45 am]
Importer of Controlled Substances
Registration: Mallinckrodt, LLC
BILLING CODE
Notice of registration.
Mallinckrodt, LLC applied to
be registered as an importer of certain
basic classes of controlled substances.
The Drug Enforcement Administration
(DEA) grants Mallinckrodt, LLC
registration as an importer of those
controlled substances.
SUPPLEMENTARY INFORMATION: By notice
dated February 5, 2015, and published
in the Federal Register on February 11,
2015, 80 FR 7634, Mallinckrodt, LLC,
3600 North Second Street, St. Louis,
Missouri 63147 applied to be registered
as an importer of certain basic classes of
controlled substances. No comments or
objections were submitted for this
notice. Comments and requests for
hearings on applications to import
narcotic raw material are not
appropriate. 72 FR 3417 (January 25,
2007).
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of
Mallinckrodt, LLC to import the basic
classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. The
DEA investigated the company’s
maintenance of effective controls
against diversion by inspecting and
testing the company’s physical security
SUMMARY:
tkelley on DSK3SPTVN1PROD with NOTICES
Controlled substance
Dated: May 15, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
Drug Enforcement Administration
ACTION:
systems, verifying the company’s
compliance with state and local laws,
and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above-named
company is granted registration as an
importer of the basic classes controlled
substances:
VerDate Sep<11>2014
20:28 May 20, 2015
Jkt 235001
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration: Fisher Clinical Services,
Inc.
ACTION:
Notice of registration.
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Controlled substance
Methylphenidate (1724) ................
Levorphanol (9220) ......................
Noroxymorphone (9668) ..............
Tapentadol (9780) ........................
Schedule
II
II
II
II
The company plans to import the
listed substances for analytical research,
testing, and clinical trials. This
authorization does not extend to the
import of a finished FDA approved or
non-approved dosage form for
commercial distribution in the United
States.
The company plans to import an
intermediate form of tapentadol (9780)
to bulk manufacture tapentadol for
distribution to its customers.
Dated: May 15, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015–12328 Filed 5–20–15; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Fisher Clinical Services, Inc.
applied to be registered as an importer
of certain basic classes of controlled
substances. The Drug Enforcement
Administration (DEA) grants Fisher
Clinical Services, Inc. registration as an
importer of those controlled substances.
SUPPLEMENTARY INFORMATION: By notice
dated January 9, 2015, and published in
the Federal Register on January 26,
2015, 80 FR 3979, Fisher Clinical
Services, Inc.,7554 Schantz Road,
Allentown, Pennsylvania 18106 applied
to be registered as an importer of certain
basic classes of controlled substances.
No comments or objections were
submitted for this notice.
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of
Fisher Clinical Services, Inc. to import
the basic classes of controlled
substances is consistent with the public
interest and with United States
SUMMARY:
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971. The DEA investigated the
company’s maintenance of effective
controls against diversion by inspecting
and testing the company’s physical
security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above-named
company is granted registration as an
importer of the basic classes of
controlled substances:
[OMB Number 1140–0062]
Agency Information Collection
Activities: Proposed eCollection
eComments Requested; Identification
of Imported Explosive Materials
Bureau of Alcohol, Tobacco,
Firearms and Explosives, Department of
Justice.
ACTION: 30-day notice.
AGENCY:
The Department of Justice
(DOJ), Bureau of Alcohol, Tobacco,
Firearms and Explosives (ATF) will
submit the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
This proposed information collection
was previously published in the 80 FR
13892 on March 17, 2015, allowing for
a 60 day comment period.
SUMMARY:
E:\FR\FM\21MYN1.SGM
21MYN1
]]>Agencies
[Federal Register Volume 80, Number 98 (Thursday, May 21, 2015)]
[Notices]
[Page 29338]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-12328]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Registration: Fisher Clinical
Services, Inc.
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: Fisher Clinical Services, Inc. applied to be registered as an
importer of certain basic classes of controlled substances. The Drug
Enforcement Administration (DEA) grants Fisher Clinical Services, Inc.
registration as an importer of those controlled substances.
SUPPLEMENTARY INFORMATION: By notice dated January 9, 2015, and
published in the Federal Register on January 26, 2015, 80 FR 3979,
Fisher Clinical Services, Inc.,7554 Schantz Road, Allentown,
Pennsylvania 18106 applied to be registered as an importer of certain
basic classes of controlled substances. No comments or objections were
submitted for this notice.
The DEA has considered the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the registration of Fisher Clinical
Services, Inc. to import the basic classes of controlled substances is
consistent with the public interest and with United States obligations
under international treaties, conventions, or protocols in effect on
May 1, 1971. The DEA investigated the company's maintenance of
effective controls against diversion by inspecting and testing the
company's physical security systems, verifying the company's compliance
with state and local laws, and reviewing the company's background and
history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the above-named company is granted
registration as an importer of the basic classes of controlled
substances:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
Methylphenidate (1724)..................... II
Levorphanol (9220)......................... II
Noroxymorphone (9668)...................... II
Tapentadol (9780).......................... II
------------------------------------------------------------------------
The company plans to import the listed substances for analytical
research, testing, and clinical trials. This authorization does not
extend to the import of a finished FDA approved or non-approved dosage
form for commercial distribution in the United States.
The company plans to import an intermediate form of tapentadol
(9780) to bulk manufacture tapentadol for distribution to its
customers.
Dated: May 15, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-12328 Filed 5-20-15; 8:45 am]
BILLING CODE P
